314 related articles for article (PubMed ID: 35185448)
1. Retinal Degeneration: A Window to Understand the Origin and Progression of Parkinson's Disease?
Zhang Y; Zhang X; Yue Y; Tian T
Front Neurosci; 2021; 15():799526. PubMed ID: 35185448
[TBL] [Abstract][Full Text] [Related]
2. Does retina play a role in Parkinson's Disease?
Mohana Devi S; Mahalaxmi I; Aswathy NP; Dhivya V; Balachandar V
Acta Neurol Belg; 2020 Apr; 120(2):257-265. PubMed ID: 31965540
[TBL] [Abstract][Full Text] [Related]
3. Characterizing the Retinal Phenotype of the Thy1-h[A30P]α-syn Mouse Model of Parkinson's Disease.
Veys L; Devroye J; Lefevere E; Cools L; Vandenabeele M; De Groef L
Front Neurosci; 2021; 15():726476. PubMed ID: 34557068
[TBL] [Abstract][Full Text] [Related]
4. Dopamine, Alpha-Synuclein, and Mitochondrial Dysfunctions in Parkinsonian Eyes.
Indrieri A; Pizzarelli R; Franco B; De Leonibus E
Front Neurosci; 2020; 14():567129. PubMed ID: 33192254
[TBL] [Abstract][Full Text] [Related]
5. Parkinson's Disease: What Can Retinal Imaging Tell Us?
Di Pippo M; d'Agostino S; Ruggeri F; Carrozzi C; Fasciolo D; Abdolrahimzadeh S
J Integr Neurosci; 2024 Jan; 23(1):23. PubMed ID: 38287853
[TBL] [Abstract][Full Text] [Related]
6. Retinal α-synuclein deposits in Parkinson's disease patients and animal models.
Veys L; Vandenabeele M; Ortuño-Lizarán I; Baekelandt V; Cuenca N; Moons L; De Groef L
Acta Neuropathol; 2019 Mar; 137(3):379-395. PubMed ID: 30721408
[TBL] [Abstract][Full Text] [Related]
7. Optical Coherence Tomography in Alzheimer's Disease and Other Neurodegenerative Diseases.
Doustar J; Torbati T; Black KL; Koronyo Y; Koronyo-Hamaoui M
Front Neurol; 2017; 8():701. PubMed ID: 29312125
[TBL] [Abstract][Full Text] [Related]
8. The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson's disease: evidence for a neuroprotective effect of rosiglitazone in the eye and brain.
Normando EM; Davis BM; De Groef L; Nizari S; Turner LA; Ravindran N; Pahlitzsch M; Brenton J; Malaguarnera G; Guo L; Somavarapu S; Cordeiro MF
Acta Neuropathol Commun; 2016 Aug; 4(1):86. PubMed ID: 27535749
[TBL] [Abstract][Full Text] [Related]
9. Parkinson's disease and the gut: Models of an emerging relationship.
Bindas AJ; Kulkarni S; Koppes RA; Koppes AN
Acta Biomater; 2021 Sep; 132():325-344. PubMed ID: 33857691
[TBL] [Abstract][Full Text] [Related]
10. Accelerated accumulation of retinal α-synuclein (pSer129) and tau, neuroinflammation, and autophagic dysregulation in a seeded mouse model of Parkinson's disease.
Mammadova N; Summers CM; Kokemuller RD; He Q; Ding S; Baron T; Yu C; Valentine RJ; Sakaguchi DS; Kanthasamy AG; Greenlee JJ; Heather West Greenlee M
Neurobiol Dis; 2019 Jan; 121():1-16. PubMed ID: 30218757
[TBL] [Abstract][Full Text] [Related]
11. Early Degeneration of Both Dopaminergic and Serotonergic Axons - A Common Mechanism in Parkinson's Disease.
Grosch J; Winkler J; Kohl Z
Front Cell Neurosci; 2016; 10():293. PubMed ID: 28066188
[TBL] [Abstract][Full Text] [Related]
12. Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson's disease.
Koutzoumis DN; Vergara M; Pino J; Buddendorff J; Khoshbouei H; Mandel RJ; Torres GE
Exp Neurol; 2020 Mar; 325():113159. PubMed ID: 31843492
[TBL] [Abstract][Full Text] [Related]
13. Saffron ameliorated motor symptoms, short life span and retinal degeneration in Parkinson's disease fly models.
Inoue E; Suzuki T; Shimizu Y; Sudo K; Kawasaki H; Ishida N
Gene; 2021 Oct; 799():145811. PubMed ID: 34224829
[TBL] [Abstract][Full Text] [Related]
14. Altered gut microbiota and intestinal permeability in Parkinson's disease: Pathological highlight to management.
Sharma S; Awasthi A; Singh S
Neurosci Lett; 2019 Nov; 712():134516. PubMed ID: 31560998
[TBL] [Abstract][Full Text] [Related]
15. Distinct retinal reflectance spectra from retinal hyperspectral imaging in Parkinson's disease.
Ueda E; Watanabe M; Nakamura D; Matsuse D; Tanaka E; Fujiwara K; Hashimoto S; Nakamura S; Isobe N; Sonoda KH
J Neurol Sci; 2024 Jun; 461():123061. PubMed ID: 38797139
[TBL] [Abstract][Full Text] [Related]
16. Oculo-visual abnormalities in Parkinson's disease: Possible value as biomarkers.
Guo L; Normando EM; Shah PA; De Groef L; Cordeiro MF
Mov Disord; 2018 Sep; 33(9):1390-1406. PubMed ID: 30311977
[TBL] [Abstract][Full Text] [Related]
17. Optical coherence tomography in Parkinson's disease: is the retina a biomarker?
Lee JY; Ahn J; Kim TW; Jeon BS
J Parkinsons Dis; 2014; 4(2):197-204. PubMed ID: 24518436
[TBL] [Abstract][Full Text] [Related]
18. Retina as a Model to Study In Vivo Transmission of α-Synuclein in the A53T Mouse Model of Parkinson's Disease.
Mammadova N; Baron T; Verchère J; Greenlee JJ; Greenlee MHW
Methods Mol Biol; 2021; 2224():75-85. PubMed ID: 33606207
[TBL] [Abstract][Full Text] [Related]
19. Imaging Biomarkers in Prodromal and Earliest Phases of Parkinson's Disease.
Theis H; Pavese N; Rektorová I; van Eimeren T
J Parkinsons Dis; 2024 Feb; ():. PubMed ID: 38339941
[TBL] [Abstract][Full Text] [Related]
20. Parkinson's disease: Autoimmunity and neuroinflammation.
De Virgilio A; Greco A; Fabbrini G; Inghilleri M; Rizzo MI; Gallo A; Conte M; Rosato C; Ciniglio Appiani M; de Vincentiis M
Autoimmun Rev; 2016 Oct; 15(10):1005-11. PubMed ID: 27497913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
